Daniel Arias
Stock Analyst at Stifel
(5.00)
# 10
Out of 5,161 analysts
170
Total ratings
57.14%
Success rate
137.81%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Buy | $20 → $25 | $18.94 | +32.00% | 8 | Mar 2, 2026 | |
| GH Guardant Health | Maintains: Buy | $120 → $130 | $84.02 | +54.73% | 6 | Feb 20, 2026 | |
| QGEN Qiagen | Maintains: Hold | $45 → $50 | $41.12 | +21.60% | 5 | Feb 6, 2026 | |
| TECH Bio-Techne | Maintains: Hold | $60 → $65 | $51.47 | +26.29% | 12 | Feb 5, 2026 | |
| ILMN Illumina | Maintains: Buy | $135 → $155 | $115.56 | +34.13% | 17 | Jan 20, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $583 → $700 | $475.89 | +47.09% | 17 | Jan 9, 2026 | |
| BLLN BillionToOne | Initiates: Buy | $145 | $64.03 | +126.46% | 1 | Dec 1, 2025 | |
| EXAS Exact Sciences | Downgrades: Hold | $80 → $105 | $103.27 | +1.68% | 8 | Nov 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,168.00 | +36.99% | 8 | Nov 10, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $35.05 | +14.12% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $12 | $7.90 | +51.90% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $110 | $84.76 | +29.78% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $260 | $186.26 | +39.59% | 10 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $0.84 | +977.84% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $6.01 | -0.17% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $49.53 | +31.23% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $283.32 | +27.06% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $111.63 | +35.27% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.29 | +203.95% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $113.76 | +81.96% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.71 | +192.40% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.30 | +334.78% | 2 | May 31, 2022 |
10x Genomics
Mar 2, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $18.94
Upside: +32.00%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $120 → $130
Current: $84.02
Upside: +54.73%
Qiagen
Feb 6, 2026
Maintains: Hold
Price Target: $45 → $50
Current: $41.12
Upside: +21.60%
Bio-Techne
Feb 5, 2026
Maintains: Hold
Price Target: $60 → $65
Current: $51.47
Upside: +26.29%
Illumina
Jan 20, 2026
Maintains: Buy
Price Target: $135 → $155
Current: $115.56
Upside: +34.13%
Thermo Fisher Scientific
Jan 9, 2026
Maintains: Buy
Price Target: $583 → $700
Current: $475.89
Upside: +47.09%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $64.03
Upside: +126.46%
Exact Sciences
Nov 28, 2025
Downgrades: Hold
Price Target: $80 → $105
Current: $103.27
Upside: +1.68%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,168.00
Upside: +36.99%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $35.05
Upside: +14.12%
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $7.90
Upside: +51.90%
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $84.76
Upside: +29.78%
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $186.26
Upside: +39.59%
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $0.84
Upside: +977.84%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.01
Upside: -0.17%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $49.53
Upside: +31.23%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $283.32
Upside: +27.06%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $111.63
Upside: +35.27%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.29
Upside: +203.95%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $113.76
Upside: +81.96%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $1.71
Upside: +192.40%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.30
Upside: +334.78%